Norges Bank’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-29,650
| Closed | -$290K | – | 2182 |
|
2016
Q3 | $290K | Sell |
29,650
-17,337
| -37% | -$170K | ﹤0.01% | 2130 |
|
2016
Q2 | $614K | Sell |
46,987
-23,900
| -34% | -$312K | ﹤0.01% | 2113 |
|
2016
Q1 | $780K | Hold |
70,887
| – | – | ﹤0.01% | 2095 |
|
2015
Q4 | $652K | Hold |
70,887
| – | – | ﹤0.01% | 2152 |
|
2015
Q3 | $492K | Sell |
70,887
-200,310
| -74% | -$1.39M | ﹤0.01% | 2191 |
|
2015
Q2 | $2.66M | Hold |
271,197
| – | – | ﹤0.01% | 2005 |
|
2015
Q1 | $2.4M | Hold |
271,197
| – | – | ﹤0.01% | 2042 |
|
2014
Q4 | $2.38M | Buy |
271,197
+163,206
| +151% | +$1.43M | ﹤0.01% | 2067 |
|
2014
Q3 | $744K | Sell |
107,991
-107,991
| -50% | -$744K | ﹤0.01% | 2226 |
|
2014
Q2 | $1.14M | Buy |
215,982
+107,991
| +100% | +$568K | ﹤0.01% | 2165 |
|
2014
Q1 | $491K | Hold |
107,991
| – | – | ﹤0.01% | 2087 |
|
2013
Q4 | $544K | Buy |
+107,991
| New | +$544K | ﹤0.01% | 2064 |
|